Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-KL Antibody (R2K70)

Catalog #:   RHJ74601 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, WB
Accession: Q9UEF7
Overview

Catalog No.

RHJ74601

Species reactivity

Human, Mouse

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Klotho, KL

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9UEF7

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2K70

Data Image
  • Western blot
    Western blot analysis of Klotho expression in human fetal kidney lysate.
References

Glucocorticoid treatment in early rheumatoid arthritis is independently associated with increased PCSK9 levels: data from a randomised controlled trial., PMID:40480650

Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons., PMID:40454418

Characterization of immunosuppression of genotype A2dB1 variant infectious bursal disease virus isolated in Malaysia using specific pathogen-free and commercial broiler chickens., PMID:40453937

Experimental Infection of Ferrets with Bartonella henselae: In Search of a Novel Animal Model for Zoonotic Bartonellosis., PMID:40430742

Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies., PMID:40404755

Proteolytic degradation of Beta-Ig H3 (βigH3/TGFBI) can be quantified non-invasively in serum and predicts prognosis in patients with advanced pancreatic ductal adenocarcinoma., PMID:40394523

Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials., PMID:40378861

Acute infectious mononucleosis generates persistent, functional EBNA-1 antibodies with high cross-reactivity to alpha-crystalline beta., PMID:40372913

Successful Management of Occult Breast Cancer with a Background of Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Pneumonia: A Case Report., PMID:40352963

Epitopes targeted by autoantibodies in presymptomatic individuals predict early rheumatoid arthritis., PMID:40348635

Effect of controlled human Plasmodium falciparum infection on B cell subsets in individuals with different levels of malaria immunity., PMID:40321757

Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: The prospective KORAIL cohort., PMID:40294559

Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY)., PMID:40243842

Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis., PMID:40241163

Serum fibrinogen is not elevated in patients with myasthenia gravis., PMID:40234551

Trop-2 expression in non-small cell lung cancer., PMID:40233061

Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study., PMID:40233040

Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey., PMID:40210218

Intranasal administration of a panreactive influenza antibody reveals Fc-independent mode of protection., PMID:40199998

Treatment of Desquamative interstitial Pneumonia and Systemic Sclerosis with Corticosteroids and Immunosuppressants: A Case Report., PMID:40189293

Pulse corticosteroid therapy in interstitial lung disease-associated with anti-aminoacyl-tRNA synthetase antibodies: Comparable efficacy with potential for reduced adverse events., PMID:40158665

Vaginally-delivered fast-dissolving antibody tablets (FDAT) for on-demand non-hormonal contraception and multi-purpose protection., PMID:40157609

Enhancing hemostasis potency in hemophilia with a small interfering ribonucleic acid targeting protein S., PMID:40154791

Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2 clinical trial., PMID:40154184

Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling., PMID:40145093

rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model., PMID:40143273

Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge Model., PMID:40143270

Target-Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III Data., PMID:40136083

Clade-specific extracellular vesicles from Akkermansia muciniphila mediate competitive colonization via direct inhibition and immune stimulation., PMID:40108178

Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection., PMID:40098097

Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8+ T cells., PMID:40081940

Streamlined High-Throughput Data Analysis Workflow for Antibody-Drug Conjugate Biotransformation Characterization., PMID:40066817

Novel method of paraffin embedding cultured cells and organoids using silicone molds., PMID:40057580

Pembrolizumab in Combination with Binimetinib in Patients with Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer., PMID:40053697

PROPERMAB: an integrative framework for in silico prediction of antibody developability using machine learning., PMID:40042626

Position-Dependent Lung Shadow Movement., PMID:40027206

Influence of surface texture on osteogenic differentiation of dental pulp stem cells: An in vitro study., PMID:40018713

Improving CD3 bispecific antibody therapy in solid tumors using combination strategies., PMID:39995843

Clinico-genomic features predict distinct metastatic phenotypes in cutaneous melanoma., PMID:39975034

Practice recommendations for respiratory syncytial virus prophylaxis among children in Hong Kong., PMID:39957107

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia., PMID:39955432

Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial., PMID:39947215

Acupuncture for the prevention of episodic migraine., PMID:39932102

A randomized, double-blind, Phase 1, single- and multiple-dose placebo-controlled study of the safety and pharmacokinetics of IN-006, an inhaled antibody treatment for COVID-19 in healthy volunteers., PMID:39923743

Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial., PMID:39910273

Cell clone selection-impact of operation modes and medium exchange strategies on clone ranking., PMID:39902171

Predicting abatacept retention using machine learning., PMID:39893489

Prolgolimab with chemotherapy as first-line treatment for advanced non-squamous non-small-cell lung cancer., PMID:39879779

Upregulation of interferon-γ response genes in monocytes and T cells identified by single-cell transcriptomics in patients with anti-citrullinated peptide antibody-positive early rheumatoid arthritis., PMID:39877346

Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease., PMID:39868614

Datasheet

Document Download

Anti-KL Antibody (R2K70).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-KL Antibody (R2K70) [RHJ74601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only